ATE485832T1 - Glucoseisomerase zur behandlung von fructose- unverträglichkeit - Google Patents

Glucoseisomerase zur behandlung von fructose- unverträglichkeit

Info

Publication number
ATE485832T1
ATE485832T1 AT08707777T AT08707777T ATE485832T1 AT E485832 T1 ATE485832 T1 AT E485832T1 AT 08707777 T AT08707777 T AT 08707777T AT 08707777 T AT08707777 T AT 08707777T AT E485832 T1 ATE485832 T1 AT E485832T1
Authority
AT
Austria
Prior art keywords
glucose
eisomerase
fructose
treatment
fructose intolerance
Prior art date
Application number
AT08707777T
Other languages
English (en)
Inventor
Daniel Wyrobnik
Isaac Wyrobnik
Original Assignee
Vitacare Gmbh & Co Kg
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=39628203&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE485832(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Vitacare Gmbh & Co Kg filed Critical Vitacare Gmbh & Co Kg
Application granted granted Critical
Publication of ATE485832T1 publication Critical patent/ATE485832T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/52—Isomerases (5)
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
    • A23L29/06—Enzymes
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A23L33/18—Peptides; Protein hydrolysates
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/20—Reducing nutritive value; Dietetic products with reduced nutritive value
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/44—Oxidoreductases (1)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/54—Mixtures of enzymes or proenzymes covered by more than a single one of groups A61K38/44 - A61K38/46 or A61K38/51 - A61K38/53
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/485—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y101/00—Oxidoreductases acting on the CH-OH group of donors (1.1)
    • C12Y101/99—Oxidoreductases acting on the CH-OH group of donors (1.1) with other acceptors (1.1.99)
    • C12Y101/99011—Fructose 5-dehydrogenase (1.1.99.11)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y302/00—Hydrolases acting on glycosyl compounds, i.e. glycosylases (3.2)
    • C12Y302/01—Glycosidases, i.e. enzymes hydrolysing O- and S-glycosyl compounds (3.2.1)
    • C12Y302/0102—Alpha-glucosidase (3.2.1.20)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y302/00—Hydrolases acting on glycosyl compounds, i.e. glycosylases (3.2)
    • C12Y302/01—Glycosidases, i.e. enzymes hydrolysing O- and S-glycosyl compounds (3.2.1)
    • C12Y302/01026—Beta-fructofuranosidase (3.2.1.26), i.e. invertase
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y503/00—Intramolecular oxidoreductases (5.3)
    • C12Y503/01—Intramolecular oxidoreductases (5.3) interconverting aldoses and ketoses (5.3.1)
    • C12Y503/01005—Xylose isomerase (5.3.1.5)
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Nutrition Science (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Mycology (AREA)
  • Inorganic Chemistry (AREA)
  • Microbiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Molecular Biology (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Steroid Compounds (AREA)
  • Nonmetallic Welding Materials (AREA)
  • Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
AT08707777T 2007-02-20 2008-02-20 Glucoseisomerase zur behandlung von fructose- unverträglichkeit ATE485832T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE102007008664.6A DE102007008664B4 (de) 2007-02-20 2007-02-20 Mittel zur Anwendung bei Fructoseintoleranz
PCT/EP2008/001294 WO2008101672A2 (en) 2007-02-20 2008-02-20 Agent for use in the case of fructose intolerance

Publications (1)

Publication Number Publication Date
ATE485832T1 true ATE485832T1 (de) 2010-11-15

Family

ID=39628203

Family Applications (1)

Application Number Title Priority Date Filing Date
AT08707777T ATE485832T1 (de) 2007-02-20 2008-02-20 Glucoseisomerase zur behandlung von fructose- unverträglichkeit

Country Status (17)

Country Link
US (11) US8460911B2 (de)
EP (5) EP2124640B1 (de)
AT (1) ATE485832T1 (de)
CA (3) CA2984999A1 (de)
CY (1) CY1120085T1 (de)
DE (2) DE102007008664B4 (de)
DK (3) DK2124640T3 (de)
ES (4) ES2700675T3 (de)
HR (2) HRP20100733T1 (de)
HU (2) HUE041311T2 (de)
IL (1) IL200517A (de)
LT (1) LT2289352T (de)
PL (4) PL2289352T3 (de)
PT (3) PT3295954T (de)
RS (1) RS51896B (de)
SI (2) SI2289352T1 (de)
WO (1) WO2008101672A2 (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20090060956A1 (en) * 2005-11-23 2009-03-05 Daniel Henry Wyrobnik Agent for reducing the useable calorie content of food and for therapeutic reduction of weight, in particular for use in the case of adiposity (obesity)
DE102007008664B4 (de) 2007-02-20 2021-07-29 Vitacare Gmbh & Co. Kg Mittel zur Anwendung bei Fructoseintoleranz
EP2764872A1 (de) * 2008-09-04 2014-08-13 Sciotec Diagnostic Technologies GmbH Behandlung von Fruktose-Malabsorption
GB201417386D0 (en) 2014-10-01 2014-11-12 Nofima As Sugar-depleted fruit or vegetable juice product, method of producing the same and use thereof to maintain health and treat and to prevent medical ailments
FI127298B (en) 2016-06-23 2018-03-15 Fazer Ab Oy Karl An enzyme with fructan hydrolase activity
US11690392B2 (en) 2018-04-18 2023-07-04 Baylor College Of Medicine Development of amyloglucosidase as a medicinal food or dietary supplement
WO2020168306A1 (en) * 2019-02-14 2020-08-20 Gutsybio Inc. Live biotherapeutics for the treatment of carbohydrate disorders
WO2022020665A2 (en) * 2020-07-23 2022-01-27 Kiwi Health, Inc Food supplement composition to aid in digestion of fructan, mannitol, and sorbitol

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6083A (en) * 1849-02-06 Cooking-stove
GB1455993A (en) * 1973-01-12 1976-11-17 Novo Industri As Glucose isomerase
US4396602A (en) * 1981-09-22 1983-08-02 Asahi Kasei Kogyo Kabushiki Kaisha Blood glucose level lowering agents
SE8505783D0 (sv) 1985-12-06 1985-12-06 Rolf Bergkvist Forfarande for framstellning av livsmedelsprodukter och dessas anvendning
US5436003A (en) * 1994-02-10 1995-07-25 Triarco Industries, Inc. Method of alleviating gastrointestinal distress with a composition containing beta-fructofuransidase, cellulase and hemi-cellulase
ATE400181T1 (de) * 1998-05-13 2008-07-15 Novozymes Inc Verfahren zur verwendung von cellobiosedehydrogenase beim backen
US7767203B2 (en) 1998-08-07 2010-08-03 Ganeden Biotech, Inc. Methods for the dietary management of irritable bowel syndrome and carbohydrate malabsorption
JP2000125883A (ja) * 1998-10-21 2000-05-09 Internatl Reagents Corp フルクトキナーゼ及びその遺伝子
AU6326699A (en) 1998-11-05 2000-05-29 Novozymes A/S Methods for using a glucose isomerase in baking
CA2328614C (en) 1999-02-12 2012-06-26 Biostream, Inc. Matrices for drug delivery and methods for making and using the same
DE60107544T2 (de) * 2000-03-01 2005-12-15 Société des Produits Nestlé S.A. Kohlenhydratformulierung (praebiotisches adjuvans) zur steigerung der immunantwort
US6646394B2 (en) * 2001-07-09 2003-11-11 Nissan Motor Co., Ltd. Control device for plurality of rotating electrical machines
US20030113310A1 (en) * 2001-12-17 2003-06-19 Van Laere Katrien Maria Jozefa Method for the treatment of obesity, overweight and fluctuations in blood insuline and/or glucose levels
US7067124B2 (en) 2003-03-28 2006-06-27 National Enzyme Company Protease composition and method for treating a digestive disorder
DE102006013624B4 (de) 2005-11-23 2012-03-15 Pro Natura Gesellschaft für gesunde Ernährung mbH Mittel zur Anwendung bei Fructoseintoleranz
PL1951290T3 (pl) * 2005-11-16 2018-05-30 Pro Natura Gesellschaft für gesunde Ernährung mbH Środek do stosowania w przypadku nietolerancji na fruktozę
WO2007059956A1 (en) * 2005-11-23 2007-05-31 Pro Natura Gesellschaft für gesunde Ernährung mbH Agent for use in the case of disorders of blood sugar metabolism, including diabetes
US20090214620A1 (en) 2005-11-23 2009-08-27 Pro Natura Gesellschaft Fuer Gesunde Ernaehrung Mb Agent for use in the case of disorders of blood sugar metabolism, including diabetes
US20090060956A1 (en) * 2005-11-23 2009-03-05 Daniel Henry Wyrobnik Agent for reducing the useable calorie content of food and for therapeutic reduction of weight, in particular for use in the case of adiposity (obesity)
DE102007008664B4 (de) 2007-02-20 2021-07-29 Vitacare Gmbh & Co. Kg Mittel zur Anwendung bei Fructoseintoleranz
US20090060656A1 (en) 2007-08-28 2009-03-05 Allied Tube & Conduit Corporation Paver edging device and method

Also Published As

Publication number Publication date
EP2289352B1 (de) 2017-11-29
DK2289352T3 (en) 2018-02-12
CA2890721C (en) 2018-01-09
DE102007008664B4 (de) 2021-07-29
US20130202696A1 (en) 2013-08-08
US20220072111A1 (en) 2022-03-10
CA2890721A1 (en) 2008-08-28
US20190282678A1 (en) 2019-09-19
US20090311232A1 (en) 2009-12-17
EP2289352A2 (de) 2011-03-02
US20130302411A1 (en) 2013-11-14
US20170319668A1 (en) 2017-11-09
ES2700675T3 (es) 2019-02-18
IL200517A (en) 2016-06-30
WO2008101672A2 (en) 2008-08-28
LT2289352T (lt) 2018-02-26
EP3295954A1 (de) 2018-03-21
HUE041311T2 (hu) 2019-05-28
US20160243207A1 (en) 2016-08-25
RS51896B (sr) 2012-02-29
US20130202695A1 (en) 2013-08-08
US20130202694A1 (en) 2013-08-08
CY1120085T1 (el) 2018-12-12
WO2008101672A3 (en) 2009-06-18
DK2124640T3 (da) 2011-01-31
US9119860B2 (en) 2015-09-01
DE602008003199D1 (de) 2010-12-09
US10842854B2 (en) 2020-11-24
DK3295954T3 (da) 2019-01-02
EP3295954B1 (de) 2018-09-12
EP3456342B1 (de) 2020-01-22
CA2984999A1 (en) 2008-08-28
US9155786B2 (en) 2015-10-13
ES2783989T3 (es) 2020-09-21
IL200517A0 (en) 2010-04-29
EP2124640A2 (de) 2009-12-02
US8460911B2 (en) 2013-06-11
SI2124640T1 (sl) 2011-03-31
HRP20180219T1 (hr) 2018-04-06
HRP20100733T1 (hr) 2011-02-28
PT2124640E (pt) 2011-01-13
PT3295954T (pt) 2018-12-17
US11826406B2 (en) 2023-11-28
ES2356357T3 (es) 2011-04-07
PT2289352T (pt) 2018-03-09
PL2289352T3 (pl) 2018-04-30
US11147861B2 (en) 2021-10-19
EP3456342A1 (de) 2019-03-20
CA2716421A1 (en) 2008-08-28
PL2124640T3 (pl) 2011-04-29
US20240335517A1 (en) 2024-10-10
US9289474B2 (en) 2016-03-22
PL3456342T3 (pl) 2020-06-15
EP2124640B1 (de) 2010-10-27
EP2289352A3 (de) 2011-05-25
DE102007008664A1 (de) 2008-08-21
EP3693005A1 (de) 2020-08-12
HUE10010195T2 (hu) 2018-07-30
ES2658123T3 (es) 2018-03-08
PL3295954T3 (pl) 2019-02-28
CA2716421C (en) 2015-07-21
SI2289352T1 (en) 2018-03-30
US20180169197A1 (en) 2018-06-21

Similar Documents

Publication Publication Date Title
DE602008003199D1 (de) Glucoseisomerase zur behandlung von fructose-unverträglichkeit
WO2009105473A3 (en) Methods and devices for follow-up care and treatment of a pneumostoma
EA201101117A1 (ru) Ингибиторы дпп-4 для лечения диабета у детей
EA201001695A1 (ru) Применение эпотилона d для лечения заболеваний, связанных с тау-белком
EP4275752A3 (de) Behandlung von erkrankungen im zusammenhang mit sucht und impulskontrolle mittels pde7-inhibitoren
UA98629C2 (ru) Соединения и способ модуляции киназ
WO2009056550A3 (en) Bupropion hydrobromide and therapeutic applications
KZ24152B (en) Method of photosensitizer activation, treatment method with application of activated photosensitizer and photosensitizer application to prepare medicine
MX2009003122A (es) Inhibidores de tirosina cinasa de bruton.
MX2010001449A (es) Bromhidrato de bupropion y aplicaciones terapeuticas.
EP2465923A3 (de) Verfahren zur Verwendung von Zellen aus Fettgewebe zur Behandlung kardiovaskulärer Erkrankungen
ATE456369T1 (de) Flibanserin zur behandlung von harninkontinenz und assoziierten erkrankungen
EP2300599A4 (de) Steigerung der wirksamkeit einer zelltherapie, einschliesslich behandlung mit alpha-1-3-fucosyltransferase
MY182983A (en) A skin external composition comprising a salt and sugar as active ingredients for preventing and treating vaginosis and the use thereof
CY1119940T1 (el) Παραγοντας για χρηση στην περιπτωση δυσανεξιας στη φρουκτοζη
JO3262B1 (ar) توليفة من ديسيتابين مع مثبط سيتيدين دي أميناز واستخدامها في علاج السرطان
WO2007028123A3 (en) Cochlear implant fitting
WO2007130501A3 (en) Combination therapy for treatment of cancer
ES2570386T3 (es) Procedimiento de lucha biológica contra Pseusomonas
UA105940C2 (uk) Лікарська комбінація з теоброміном та опіатом і її використання в лікуванні кашлю
UA92593C2 (ru) Лечение мастита энрофлоксацином
MA32355B1 (fr) Association de la dronedarone avec au moins un diuretique, son application en therapeutique
NZ598124A (en) Compounds for treatment of inflammation
WO2009105507A3 (en) Beloxepin, its enantiomers, and analogs thereof for the treatment of pain
EA200800722A1 (ru) Средство, активирующее стволовые клетки и/или клетки-предшественники

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 2124640

Country of ref document: EP